Generation of a genetically double-attenuated Plasmodium berghei parasite that fully arrests growth during late liver stage development
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0316164 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Melanie Schmid und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Cell Biology, University of Bern, Bern, Switzerland. Hauptthemen laut MEDLINE: Plasmodium berghei, Liver, Malaria. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swiss National Science Foundation, Multidisciplinary Center for Infectious Diseases.
Abstract (Originalsprache)
Malaria caused by Plasmodium parasites remains a large health burden. One approach to combat this disease involves vaccinating individuals with whole sporozoites that have been genetically modified to arrest their development at a specific stage in the liver by targeted gene deletion, resulting in a genetically attenuated parasite (GAP). Through a comprehensive phenotyping screen, we identified the hscb gene, encoding a putative iron-sulfur protein assembly chaperone, as crucial for liver stage development, making it a suitable candidate gene for GAP generation. Parasites lacking Plasmodium berghei HscB ( Pb HscB) exhibited normal sporozoite production in mosquitoes, but their liver stage development was severely impaired, characterized by slow growth and delayed expression of merozoite surface protein 1 (MSP1). In vivo experiments demonstrated that Pb HscB-deficient parasites exhibited a delay in prepatency of 2–4 days, emphasizing the significance of Pb HscB for exo-erythrocytic development. Although knockout of Pb HscB alone allowed breakthrough infections, it is a potent candidate for a dual gene deletion strategy. PlasMei2, an RNA-binding protein, was previously found to be crucial for the completion of liver stage development. We generated a Pb HscB- Pb Mei2-double attenuated parasite line, serving as a late liver stage-arresting replication-competent (LARC) GAP, providing a solid block of liver-to-blood stage transition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Cell Biology, University of Bern, Bern, Switzerland.
- Graduate School for Cellular and Biomedical Sciences, University of Bern, Bern, Switzerland.
ORCID-Profile: Volker Heussler, Magali Roques
Förderung
- Swiss National Science Foundation
- Multidisciplinary Center for Infectious Diseases
Zitieren
APA
Schmid, M., Beyeler, R., Caldelari, R., Rehmann, R., Heussler, V., & Roques, M. (2024). Generation of a genetically double-attenuated Plasmodium berghei parasite that fully arrests growth during late liver stage development. PLOS ONE. https://doi.org/10.1371/journal.pone.0316164
Vancouver
Schmid M, Beyeler R, Caldelari R, Rehmann R, Heussler V, Roques M. Generation of a genetically double-attenuated Plasmodium berghei parasite that fully arrests growth during late liver stage development. PLOS ONE. 2024. doi:10.1371/journal.pone.0316164
BibTeX
@article{Schmid2024,
author = {Schmid, Melanie and Beyeler, Raphael and Caldelari, Reto and Rehmann, Ruth and Heussler, Volker and Roques, Magali},
title = {Generation of a genetically double-attenuated Plasmodium berghei parasite that fully arrests growth during late liver stage development},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0316164}
}
EUVIMED